1 ML Fasenra 30 MG/ML Prefilled Syringe
- RxCUI
- 1989109
- RxNorm name
- 1 ML Fasenra 30 MG/ML Prefilled Syringe
- Display name
- 1 ML Fasenra 30 MG/ML Prefilled Syringe
- Full name
- 1 ML Fasenra 30 MG/ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761070 | Fasenra | benralizumab | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FASENRA | BENRALIZUMAB | AstraZeneca Pharmaceuticals LP | da6aca1a-19ed-44a4-abb7-696c7d58b784 | 2026-05-13 | Warnings, Adverse reactions | 1989109 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| da6aca1a-19ed-44a4-abb7-696c7d58b784 | 1 ML Fasenra 30 MG/ML Prefilled Syringe | SY | 27 | These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260513 |
| da6aca1a-19ed-44a4-abb7-696c7d58b784 | 1 ML benralizumab 30 MG/ML Prefilled Syringe [Fasenra] | SBD | 27 | These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260513 |
| da6aca1a-19ed-44a4-abb7-696c7d58b784 | Fasenra 30 MG in 1 ML Prefilled Syringe | PSN | 27 | These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260513 |
| da6aca1a-19ed-44a4-abb7-696c7d58b784 | Fasenra 30 MG per 1 ML Prefilled Syringe | SY | 27 | These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | 20260513 |